Cannabis patch startup pulls off a $42M IPO to fund drugs for epilepsy, pain

Damian Garde

Pennsylvania drugmaker Zynerba Pharmaceuticals is making its way to Wall Street with some -derived treatments for central nervous system disorders, raising $ 42 million in an IPO.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS